- Home
- RVPH vs EQH Comparison
RVPH vs EQH Comparison
Compare RVPH & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- EQH
- Stock Information
- Founded
- RVPH 2006
- EQH 1859
- Country
- RVPH United States
- EQH United States
- Employees
- RVPH N/A
- EQH N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- EQH Specialty Insurers
- Sector
- RVPH Health Care
- EQH Finance
- Exchange
- RVPH Nasdaq
- EQH Nasdaq
- Market Cap
- RVPH 30.1M
- EQH 16.2B
- IPO Year
- RVPH N/A
- EQH N/A
- Fundamental
- Price
- RVPH $0.41
- EQH $53.53
- Analyst Decision
- RVPH Strong Buy
- EQH Buy
- Analyst Count
- RVPH 5
- EQH 11
- Target Price
- RVPH $5.20
- EQH $64.55
- AVG Volume (30 Days)
- RVPH 1.2M
- EQH 2.7M
- Earning Date
- RVPH 11-13-2025
- EQH 11-03-2025
- Dividend Yield
- RVPH N/A
- EQH 2.05%
- EPS Growth
- RVPH N/A
- EQH N/A
- EPS
- RVPH N/A
- EQH 1.38
- Revenue
- RVPH N/A
- EQH $13,960,000,000.00
- Revenue This Year
- RVPH N/A
- EQH $17.36
- Revenue Next Year
- RVPH N/A
- EQH $1.25
- P/E Ratio
- RVPH N/A
- EQH $38.17
- Revenue Growth
- RVPH N/A
- EQH 21.29
- 52 Week Low
- RVPH $0.30
- EQH $40.38
- 52 Week High
- RVPH $4.28
- EQH $56.61
- Technical
- Relative Strength Index (RSI)
- RVPH 37.91
- EQH 52.49
- Support Level
- RVPH $0.50
- EQH $52.52
- Resistance Level
- RVPH $0.47
- EQH $54.43
- Average True Range (ATR)
- RVPH 0.03
- EQH 1.17
- MACD
- RVPH -0.01
- EQH -0.01
- Stochastic Oscillator
- RVPH 23.50
- EQH 65.12
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.